Breakthrough trial reduces brain inflammation in Parkinson's patients
Scientists at Macquarie University have successfully reduced brain inflammation in patients at high risk of Parkinson's disease through a new clinical trial. The study showed that patients on the drug experienced clinical improvements and reduced inflammation linked to cell loss, while those not on the drug deteriorated.
See omnystudio.com/listener for privacy information.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.